Their pipeline is much deeper than the asthma drug, I stated this last week they remind me a lot of INCY. I think it is one of the better 5 dollar stocks around could quickly run to over a billion in market cap. I like Transition as well they have couple of interesting small molecues and low float. Biotech has changed a little over the last year or so these companies are getting more recognition and sleepers like TSRX and ARRY do not hang around for ever. I am afraid all of these cancer agents are going to kill each other in the long run but I do not view CLDX in that boat over 50% of drugs in research are in oncology. That is why Asthma, Pain and Joint, Mental Illness are so huge and that is why Regeneron is over 200 because of the cholesterol agents in research.
You have that right Ray,
I always like to double up, when a offering is announced, and the fools sell their stock.
There is a nice piece of change to be made on the recovery after the offering is completed.